Literature DB >> 26629069

Expression and significance of miR155 and vascular endothelial growth factor in placenta of rats with preeclampsia.

Qian Liu1, Jing Yang1.   

Abstract

OBJECTIVE: This study is to investigate the expression and significance of miR155 and vascular endothelial growth factor (VEGF) in placenta of preeclampsia (PE) model rats.
METHODS: A total of 20 SD rats were randomly divided into normal pregnant group and PE model group. PE model was established by subcutaneous injection of L nitro arginine methyl ester continuously for 4 days with a dosage of 200 mg/Kg·d from the 13th day of pregnancy. Blood pressure, urinary protein and renal function were detected to evaluate fetal development. Real-time fluorescent quantitative polymerase chain reaction was used to test the expression of placental miR155. Western-blot assay and ELISA were performed to detect the expression of placental VEGF protein.
RESULTS: Blood pressure, urine protein, blood urea nitrogen and creatinine in PE model group were higher than in normal pregnant group, and there was statistically significant (P < 0.05). Expression of miR155 in PE group was higher than that of normal pregnant group and VEGF protein expression was lower than that in normal pregnant group, both were statistically significant (P < 0.01).
CONCLUSION: In PE model group, miR155 expression significantly increases whereas the expression of VEGF decreases. PE might be correlated with the down regulation of VEGF by miR155.

Entities:  

Keywords:  MiR155; preeclampsia; rat model; vascular endothelial growth factor

Year:  2015        PMID: 26629069      PMCID: PMC4658958     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  16 in total

1.  T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC.

Authors:  Deanna Haasch; Yung-Wu Chen; Regina M Reilly; X Grace Chiou; Sandra Koterski; Morey L Smith; Paul Kroeger; Kerri McWeeny; Donald N Halbert; Karl W Mollison; Stevan W Djuric; James M Trevillyan
Journal:  Cell Immunol       Date:  2002 May-Jun       Impact factor: 4.868

Review 2.  MicroRNAs and their regulatory roles in animals and plants.

Authors:  Baohong Zhang; Qinglian Wang; Xiaoping Pan
Journal:  J Cell Physiol       Date:  2007-02       Impact factor: 6.384

3.  Placental circulation: Clinical significance.

Authors:  M Zygmunt
Journal:  Early Pregnancy       Date:  2001-01

4.  Hypoxia up-regulates hypoxia-inducible factor-1alpha expression through RhoA activation in trophoblast cells.

Authors:  Masami Hayashi; Masahiro Sakata; Takashi Takeda; Masahiro Tahara; Toshiya Yamamoto; Ryoko Minekawa; Aki Isobe; Keiichi Tasaka; Yuji Murata
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

5.  Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.

Authors:  S AbdAlla; H Lother; A el Massiery; U Quitterer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

6.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Authors:  Meritxell Gironella; Mylène Seux; Min-Jue Xie; Carla Cano; Richard Tomasini; Julien Gommeaux; Stephane Garcia; Jonathan Nowak; Man Lung Yeung; Kuan-Teh Jeang; Amandine Chaix; Ladan Fazli; Yoshiharu Motoo; Qing Wang; Palma Rocchi; Antonio Russo; Martin Gleave; Jean-Charles Dagorn; Juan L Iovanna; Alice Carrier; Marie-Josèphe Pébusque; Nelson J Dusetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

7.  Regulation of the germinal center response by microRNA-155.

Authors:  To-Ha Thai; Dinis Pedro Calado; Stefano Casola; K Mark Ansel; Changchun Xiao; Yingzi Xue; Andrew Murphy; David Frendewey; David Valenzuela; Jeffery L Kutok; Marc Schmidt-Supprian; Nikolaus Rajewsky; George Yancopoulos; Anjana Rao; Klaus Rajewsky
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

8.  Effect of impaired glucose tolerance during pregnancy on the expression of VEGF receptors in human placenta.

Authors:  M Marini; D Vichi; A Toscano; G D Zappoli Thyrion; L Bonaccini; E Parretti; G Gheri; A Pacini; E Sgambati
Journal:  Reprod Fertil Dev       Date:  2008       Impact factor: 2.311

Review 9.  Molecular mechanisms of preeclampsia.

Authors:  Walter P Mutter; S Ananth Karumanchi
Journal:  Microvasc Res       Date:  2007-05-06       Impact factor: 3.514

10.  Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia.

Authors:  Tina Cronqvist; Karen Saljé; Mary Familari; Seth Guller; Henning Schneider; Chris Gardiner; Ian L Sargent; Christopher W Redman; Matthias Mörgelin; Bo Åkerström; Magnus Gram; Stefan R Hansson
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more
  5 in total

Review 1.  The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia.

Authors:  Tashlen Abel; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2021-04-13       Impact factor: 5.369

Review 2.  New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease.

Authors:  Brian H Annex; John P Cooke
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

Review 3.  Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the Disease.

Authors:  Adam M Sheikh; Heather Yvonne Small; Gemma Currie; Christian Delles
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

Review 4.  MicroRNAs: New Players in the Pathobiology of Preeclampsia.

Authors:  Kelsey R Bounds; Valorie L Chiasson; Lu J Pan; Sudhiranjan Gupta; Piyali Chatterjee
Journal:  Front Cardiovasc Med       Date:  2017-09-25

Review 5.  MicroRNAs in Uteroplacental Vascular Dysfunction.

Authors:  Xiang-Qun Hu; Lubo Zhang
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.